What are Semaglutide, Tirzepatide, and Retatrutide? Ask Chicago's Expert.

Key Takeaways: Semaglutide vs. Tirzepatide vs. Retatrutide

• Semaglutide is a proven, FDA-approved GLP-1 agonist for weight loss (15–20% body weight reduction in clinical trials)
• Tirzepatide is a dual GIP/GLP-1 agonist showing up to 22% weight loss in trials — often more potent than Semaglutide for some patients
• Retatrutide is an experimental triple agonist with promising early results, but is NOT FDA-approved and not yet available at Better Med Spa
• All three require medical supervision, lifestyle changes, and ongoing monitoring for safe, sustainable results
• Better Med Spa in Lincoln Park currently offers Semaglutide and Tirzepatide with physician-directed protocols, slow titration, and holistic wellness integration

Quick Comparison: Semaglutide vs. Tirzepatide vs. Retatrutide (2026)

Semaglutide

• Mechanism: GLP-1 receptor agonist
• FDA Status: Approved for diabetes and weight management
• Expected Weight Loss: 15–20% body weight
• Administration: Weekly injection
• Onset: Appetite changes within first few weeks
• Cost: Membership pricing at Better Med Spa — see plans

Tirzepatide

• Mechanism: Dual GIP + GLP-1 receptor agonist
• FDA Status: Approved for diabetes and weight management
• Expected Weight Loss: Up to 22% body weight
• Administration: Weekly injection
• Onset: Often faster appetite suppression
• Cost: Membership pricing at Better Med Spa — see plans

Retatrutide

• Mechanism: Triple agonist (GLP-1 + GIP + Glucagon)
• FDA Status: NOT approved — investigational only
• Expected Weight Loss: Early data suggests very potent effects (up to 24% in trials)
• Administration: Weekly injection (investigational protocols)
• Onset: Under investigation
• Cost: Not yet available

What Are Semaglutide, Tirzepatide, and Retatrutide?

All three of these medications are part of a new generation of metabolic therapies originally developed for diabetes and obesity. They work by mimicking or amplifying gut hormones that help regulate appetite, blood sugar, and how the brain responds to food.

• Semaglutide – A GLP‑1 receptor agonist.
• Tirzepatide – A dual GIP/GLP‑1 receptor agonist.
• Retatrutide – An emerging triple agonist (GLP‑1, GIP, and glucagon receptors) currently under active study and not FDA-approved for weight loss or general wellness; at Better Med Spa it is planned to be offered once clinical approval occurs.

These medications can be very effective for both blood sugar control and weight reduction in appropriate patients, but they also come with potential risks and side effects and must be prescribed and monitored by licensed medical professionals.

How Semaglutide Works

Semaglutide acts like a hormone called GLP‑1, which is naturally released from your gut when you eat. By activating GLP‑1 receptors more strongly and for longer, semaglutide:

• Slows gastric emptying (food leaves your stomach more slowly).
• Helps your pancreas release insulin in a glucose-dependent way.
• Reduces glucagon secretion.
• Sends stronger “I’m full” signals to the brain.

For many patients, this leads to smaller portions feeling satisfying, fewer cravings, improved blood sugar control, and gradual weight loss when combined with dietary changes and movement. It is FDA‑approved at specific doses and brand names for type 2 diabetes and chronic weight management in defined populations when combined with lifestyle interventions.

How Tirzepatide Is Different

Tirzepatide is often described as a “dual agonist” because it targets two hormone systems: GLP‑1 and GIP (glucose‑dependent insulinotropic polypeptide). By acting on both receptors, it:

• Enhances insulin secretion when blood sugar is high.
• Suppresses glucagon when appropriate.
• Modulates appetite and fullness signals.
• Appears to have a strong effect on body weight in many patients.

Tirzepatide is FDA‑approved for specific indications, including type 2 diabetes and, at certain doses and brand names, chronic weight management in adults with defined BMI criteria plus at least one weight-related condition, when combined with lifestyle change. In practice, some patients respond to tirzepatide with more pronounced weight loss than semaglutide, but individual response varies.

What Makes Retatrutide Different — And Why It’s Not Yet Available

Retatrutide is a newer “triple agonist,” targeting GLP‑1, GIP, and glucagon receptors. Early clinical trials suggest it may have very potent effects on weight and metabolic markers, but:

• It is not FDA‑approved for weight loss or general wellness.
• Long-term safety data are still being collected.
• Optimal dosing, duration, and patient selection are still under investigation.

Because of this, at Better Med Spa:

• Retatrutide is not yet offered and is described for informational purposes only.
• It is reserved for future offering once FDA or compounding legality moves forward.
• Patients will receive detailed counseling about risks, benefits, and unknowns when it becomes available.

Common Benefits — And What They Depend On

Patients often pursue these medications for:

• Meaningful, sustainable weight loss.
• Better control of type 2 diabetes.
• Reduced cravings and emotional or “compulsive” eating.
• Improved markers like A1C, fasting glucose, and certain cardiovascular risk factors.

But all of these improvements are highly individual, strongly influenced by nutrition, movement, sleep, stress, and existing medications, and dependent on correct use, appropriate dose, and adequate monitoring.

No injectable replaces healthy eating, movement, or care from your primary doctor or specialist. At Better Med Spa, these medications are framed as tools, not cures.

Side Effects and Safety Considerations

The most common side effects across GLP‑1/GIP/glucagon agonists include:

• Nausea, vomiting, or reduced appetite that feels “too strong.”
• Diarrhea or constipation.
• Bloating, heartburn, or abdominal discomfort.
• Fatigue or feeling “off” while the body adjusts.

More serious potential risks include (not an exhaustive list):

• Pancreatitis.
• Gallbladder issues (gallstones, inflammation).
• Worsening of certain pre‑existing digestive conditions.
• Possible impact on certain eye conditions in people with diabetes.
• Unknown long-term effects, especially for newer agents like retatrutide.

People with specific histories—such as medullary thyroid carcinoma, MEN 2, certain pancreatic or gallbladder diseases—may not be appropriate candidates. That’s why these medications should only be used under the guidance of a licensed clinician who reviews your history, medications, and lab work.

GLP-1 Weight Loss Costs at Better Med Spa, Lincoln Park

Better Med Spa offers competitive, transparent pricing for GLP-1 weight loss programs in Lincoln Park, Chicago:

• Semaglutide: Monthly and quarterly membership plans including weekly injections, medical oversight, and follow-up support
• Tirzepatide: Monthly and quarterly membership plans with dual-action metabolic support
• Consultations: Comprehensive medical evaluation to determine the right medication and dosing for your goals

Visit our memberships page for current pricing or contact us directly. All programs include medical supervision, dose adjustments, and ongoing monitoring.

How Better Med Spa Approaches These Medications

1. Medical Evaluation First

Before starting semaglutide or tirzepatide, you’ll complete a comprehensive intake, medical history review, current medication review, and baseline measurements. This helps determine if you’re a candidate and which medication and dose makes sense.

2. Clear Framing and Informed Consent

You’ll discuss FDA-approved indications, expected benefits vs. unknowns, side effects, red-flag symptoms, and when to seek care. Nothing starts without fully informed consent.

3. Slow, Structured Titration

Doses start low and increase gradually to reduce side effects and allow your body to adjust. Rushing titration is one of the biggest reasons people feel terrible on these medications.

4. Lifestyle Integration

Our team helps you use the “appetite quiet” to learn proper portions, focus on protein and nutrient-dense foods, build realistic movement, and address sleep and stress.

5. Regular Follow-ups and Adjustments

Follow-ups monitor side effects, adjust dosing, and decide when to pause, maintain, or taper.

Who Might Be a Good Candidate?

You may be a good candidate if:

• You meet BMI and/or metabolic criteria commonly used in medical weight management
• You’ve already tried structured lifestyle changes and still struggle
• You are under the care of a primary physician
• You’re willing to have labs and regular follow-ups
• You understand these medications are medical tools, not cosmetic quick fixes

You may not be a good candidate if you have a disordered eating history, are pregnant or breastfeeding, have specific endocrine or gastrointestinal diseases, or want a “set it and forget it” solution.

Start Your Weight Loss Journey in Lincoln Park

Powerful tools demand thoughtful use. At Better Med Spa, semaglutide and tirzepatide are never treated as trendy “shots” but as serious medications that can help the right person when layered onto a realistic plan for health.

If you’re in Lincoln Park or anywhere in Chicago and want to know whether one of these options belongs in your journey, book a medical consultation. You’ll get space to ask questions, talk through your history, and understand which medication, if any, makes sense for your body, your lifestyle, and your long-term goals.

Related treatments:

• Semaglutide treatment page
• Tirzepatide treatment page
• Weight Loss & Contouring programs
• Membership plans

The content provided on this blog is for educational purposes only and does not substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of your healthcare provider for any questions regarding your health or medical conditions.